Economic evaluation in psychiatric pharmacogenomics: a systematic reviewKariofyllis Karamperis, Christina Mitropoulou, Maria Koromina et al.|The Pharmacogenomics Journal|2021Cited by 59
Clinical implementation of preemptive pharmacogenomics in psychiatryΜαρία Σκώκου, Athanassios Vozikis, Kariofyllis Karamperis et al.|EBioMedicine|2024Cited by 56
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, G. Koumakis, Athina Christopoulou et al.|ESMO Open|2020Cited by 38